AUSTIN, Texas--(BUSINESS WIRE)--Resource savings of 60% overall (80% in the start-up stage) can be reaped in a clinical research study with the implementation of standards developed by the Clinical Data Interchange Standards Consortium. Over half of the value is realized if the standards are implemented in the start-up stage of the study. These findings, and others, resulted from a project that was conducted with Gartner and sponsored by the Pharmaceutical Research Manufacturers Association (PhRMA) to assess the Business Case for CDISC standards.
